Clinical Trial Update: Pharmacokinetics of Lamivudine at Two Different Doses [Phase 1, Phase 2]

View source ↗

Summary

The document reports pharmacokinetic findings for lamivudine at two different doses from a Phase 1/2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED